Monitor for significant dilution from warrant exercises and option grants; watch for updates on creditor negotiations and trial restarts which could materially impact valuation; Wyoming domestication may signal regulatory or tax strategy shift
Price Chart
Executive Summary
Bio-Path Holdings issued Series S Preferred stock and warrants to its CEO's advisory firm, canceled a planned reverse split, and disclosed efforts to restructure operations and restart clinical trials. These actions consolidate control with management and signal a turnaround attempt amid financial distress.
Key Facts
- Issued 51 shares of Series S Preferred stock and 2 million warrants to Steel Giants Advisors LLC (controlled by CEO Vikram Grover), granting it 1% of diluted votes
- Used $10,000 in accrued payables as consideration for the issuance
- Canceled a previously approved 1-for-30 reverse stock split due to low outstanding shares
- Engaged Farrington Capital Group for $1,000 cash and 100,000 shares to enhance technological platforms
- Reserved 1.5 million stock options for a new Strategic Advisory Board
- In negotiations with creditors to restructure payables and potentially restart Phase 1/2 trials for AML, solid tumors, and obesity
- Filed to domesticate the corporation from Delaware to Wyoming
Financial Impact
$10,000 in payables converted to equity; 2.1 million new shares potentially issuable (2M via warrants, 51 via preferred conversion); 1.5M options reserved
Risk Factors
- Extreme shareholder dilution from warrant and option issuances
- Related-party transaction concerns with CEO-controlled entity receiving preferential terms
- Failure to restructure debt or restart trials could lead to continued operational decline
- OTC listing with low liquidity amplifies volatility risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001663577-26-000046 |
| Document: 0001663577-26-000046-index-headers.html | 0001663577-26-000046 |
| Document: 0001663577-26-000046-index.html | 0001663577-26-000046 |
| Document: 0001663577-26-000046.txt | 0001663577-26-000046 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 16, 2026 14w ago | 8-K | $0.0400 $0.000200 | ▲ +99.50% | ▲ +103.47% | $0.000300 (+99.25%) |
May 26, 2026 22w ago | 8-K | $0.0400 $0.0339 | ▲ +15.25% | ▲ +17.97% | $0.000300 (+99.25%) |
Feb 24, 2026 35w ago | 8-K | $0.0700 $0.0200 | ▼ −71.43% | ▼ −78.18% | $0.000300 (−99.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers